title: Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study.
authors.affiliation: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India.
authors.forename: Y
authors.initials: Y
authors.lastname: Ashokraj
authors.forename: S
authors.initials: S
authors.lastname: Agrawal
authors.forename: M V S
authors.initials: MV
authors.lastname: Varma
authors.forename: I
authors.initials: I
authors.lastname: Singh
authors.forename: K
authors.initials: K
authors.lastname: Gunjan
authors.forename: K J
authors.initials: KJ
authors.lastname: Kaur
authors.forename: S R
authors.initials: SR
authors.lastname: Bhade
authors.forename: C L
authors.initials: CL
authors.lastname: Kaul
authors.forename: J M
authors.initials: JM
authors.lastname: Caudron
authors.forename: J
authors.initials: J
authors.lastname: Pinel
authors.forename: R
authors.initials: R
authors.lastname: Panchagnula
mesh_terms: D000904:Antibiotics, Antitubercular / Q000737:chemistry / Q000493:pharmacokinetics / Q000592:standards*; D000995:Antitubercular Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000592:standards*; D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D004345:Drug Industry; D004359:Drug Therapy, Combination; D014943:Global Health; D006801:Humans; D019064:Product Packaging; D011786:Quality Control; D012293:Rifampin / Q000737:chemistry / Q000493:pharmacokinetics / Q000592:standards*; D012995:Solubility; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
chemical_list: D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D012293:Rifampin